EU project develops software to improve brain tumour diagnosis

A recently launched EU funded HealthAgents project (and recent Best IST Project Website Award winner) is developing software which is likely to give doctors everywhere much-needed help in the early diagnosis and treatment of brain tumours.

Brain tumours remain an important cause of mortality and afflict a large percentage of the European population. In children over one year of age, brain tumours are the most common solid malignancies that cause disease-related death.

A brain tumour diagnosis usually involves using Magnetic Resonance Spectroscopy (MRS), a non-invasive technique, to determine the tissue biochemical composition of a tumour. But such scans only achieve 60-90% accuracy, depending on the tumour type and grade.

Diagnosing a tumour, therefore, also requires taking a surgical biopsy, which can be potentially deadly for patients. For tumours that evolve slowly - mainly in children - repeated biopsies are often needed, but are not advisable.

Now, research teams from Belgium, Italy, Spain and the UK, working together in HealthAgents - a €4.5 initiative - hope that with their software, biopsies will no longer be necessary.

They will develop a database in which hi-tech scans, conducted on patients in hospitals from all around Europe, may be stored and classified. Using pattern recognition techniques, the system will enable doctors to compare the scan results with those from similar cases from other hospitals. The software will then suggest a series of diagnoses, leaving the doctor to choose the best type of treatment.

According to Dr Andrew Peet, clinical advisor to HealthAgents, the project gives doctors access to a range of securely held results that would simply not have been available previously. "The consortium encompasses a wide range of talent from universities, companies and hospitals. The expertise of the consortium will provide the foundations for the first EU grid for brain tumour diagnosis and prognosis. We will profit from a world-class data exchange network to address one of the most pernicious diseases of our time," he said.

For further information, please visit:
www.healthagents.net

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...